{"a":[{"_":"Geopolitics ‘chills’ British biotech IPO plans, despite $2B in Q2 VC funds ","$":{"href":"/biotech/geopolitics-chills-british-biotech-ipo-plans-despite-2b-q2-vc-funds","hreflang":"en"}}]}

IPO/OfferingNegative

AI Analysis

Summary

Geopolitical uncertainty is dampening IPO sentiment among British biotechs despite the sector receiving $2 billion in venture capital funding during Q2 2026, marking a five-year high.

Importance:3/10

Sentiment:

-0.40

IPOBritish biotechgeopolitical uncertaintyventure capitalQ2 2026

Read the original article

Published by FierceBiotech on July 19, 2026 8:59 AM

Read Original